Recent publications in medical microbiology and immunology: A retrospective

Medical Microbiology and Immunology

Volumn 201, Issue 1, 2012, Pages 1-5

  Doerr, H W ^a   Cinatl, J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

AIDS; Herpesviruses; Immune response; Influenza; Pathogen variation; Tuberculosis; Viral hepatitis

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; CELLULAR IMMUNITY; COMMUNICABLE DISEASE; CYTOMEGALOVIRUS INFECTION; EUROPE; HERPES ZOSTER; HOST PARASITE INTERACTION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION PREVENTION; INFLUENZA; INFLUENZA A (H1N1); INNATE IMMUNITY; MEASLES; MOLECULAR PATHOLOGY; MOLECULAR THERAPY; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REVIEW; TROPICAL DISEASE; VACCINATION; VACCINE PRODUCTION; VIRUS HEPATITIS; VIRUS VIRULENCE; ANIMAL; HEPATITIS C; HERPES VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOLOGY; MEDICAL RESEARCH; MICROBIOLOGY; RETROSPECTIVE STUDY; SWINE; TUBERCULOSIS; VIROLOGY; VIRULENCE; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; BIOMEDICAL RESEARCH; HEPATITIS C; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNE SYSTEM; INFLUENZA, HUMAN; RETROSPECTIVE STUDIES; SWINE; TUBERCULOSIS; VACCINES; VIRULENCE; VIRUS DISEASES;

EID: 84863446444     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-011-0219-9     Document Type: Review

References (74)

1. Cinatl J Jr, Michaelis M, Doerr HW (2007) The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants. Med Microbiol Immunol 196:181-190
2. Cinatl J Jr, Michaelis M, Doerr HW (2007) The threat of avian influenza A (H5N1). Part IV: development of vaccines. Med Microbiol Immunol 196:213-225
3. Doerr HW, Varwig D, Allwinn R, Cinatl J (2006) Will the next human influenza pandemic be caused by the virus of the avian flu A/H5N1? Arguments pro and counter. Med Microbiol Immunol 195:45-47
4. Michaelis M, Doerr HW, Cinatl J Jr (2009) Of chickens and men: avian influenza in humans. Curr Mol Med 9:131-151
5. Rabenau HF, Richter M, Doerr HW (2010) Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and enterovirus 71 in Germany. Med Microbiol Immunol 199:45-51
6. Michaelis M, Doerr HW, Cinatl J Jr (2009) Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol 198:175-183
7. Michaelis M, Doerr HW, Cinatl J Jr (2009) An influenza A H1N1 virus revival-pandemic H1N1/09 virus. Infection 37:381-389
8. Krumbholz A, Philipps A, Oehring H, Schwarzer K, Eitner A et al (2011) Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol 200:69-75
9. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr (2011) Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 200:53-60
10. Bhakdi S, Lackner K, Doerr HW (2009) Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed? Med Microbiol Immunol 198:205-209
11. Han F, Lin L, Warby SC, Faraco J, Li J et al (2011) Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china. Ann Neurol 70:410-417
12. Doerr HW, Allwinn R, Cinatl J (2009) Against the new H1N1 influenza (swine influenza): vaccinate or don't vaccinate (all) ? That is currently the question! Infection 37:379-380
13. Bickel M, von Hentig N, Wieters I, Khaykin P, Nisius G et al (2011) Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients. Clin Infect Dis 52:122-127
14. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW (2010) Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol 199:117-121
15. Reinheimer C, Allwinn R, Doerr HW (2010) Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010. Infection 39:101-104
16. Allwinn R, Preiser W, Rabenau H, Buxbaum S, Sturmer M et al (2002) Laboratory diagnosis of influenza-virology or serology? Med Microbiol Immunol 191:157-160
17. Sauerbrei A, Schmidt-Ott R, Hoyer H, Wutzler P (2009) Seroprevalence of influenza A and B in German infants and adolescents. Med Microbiol Immunol 198:93-101
18. Michaelis M, Doerr HW, Cinatl J Jr (2011) Investigation of the influence of EPs (R) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine 18:384-386
19. Michaelis M, Geiler J, Naczk P, Sithisarn P, Leutz A et al (2011) Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and proinflammatory gene expression. PLoS One 6:e19705
20. Michaelis M, Geiler J, Naczk P, Sithisarn P, Ogbomo H et al (2010) Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virusinduced pro-inflammatory cytokine and chemokine expression in human macrophages. Med Microbiol Immunol 199:291-297
21. Wiesener N, Zimmer C, Jarasch-Althof N, Wutzler P, Henke A (2011) Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate. Med Microbiol Immunol 200:115-126
22. Ogbomo H, Michaelis M, Geiler J, van Rikxoort M, Muster T et al (2010) Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells. Med Microbiol Immunol 199:93-101
23. Peveling-Oberhag J, Zeuzem S, Hofmann WP (2010) Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation. Med Microbiol Immunol 199:1-10
24. Riva E, Maggi F, Abbruzzese F, Bellomi F, Giannelli G et al (2009) Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients. Med Microbiol Immunol 198:13-18
25. Sturmer M, Doerr HW, Gurtler L (2009) Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus. Med Microbiol Immunol 198:147-155
26. Mendiratta S, Vajpayee M, Malhotra U, Kaushik S, Dar L et al (2009) Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals. Med Microbiol Immunol 198:47-56
27. Reuter S, Oette M, Wilhelm FC, Beggel B, Kaiser R et al (2011) Prevalence and characteristics of hepatitis B and C virus infections in treatment-naive HIV-infected patients. Med Microbiol Immunol 200:39-49
28. Sturmer M, Zimmermann K, Fritzsche C, Reisinger E, Doelken G et al (2010) Regional spread of HIV-1 M subtype B in middleaged patients by random env-C2V4 region sequencing. Med Microbiol Immunol 199:123-128
29. Bhakdi S, Lackner KJ, Han SR, Torzewski M, Husmann M (2004) Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb Haemost 91:639-645
30. Lubeck PR, Doerr HW, Rabenau HF (2010) Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol 199:53-60
31. Michaelis M, Doerr HW, Cinatl J Jr (2009) Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol 198:79-81
32. Michaelis M, Baumgarten P, Mittelbronn M, Driever PH, Doerr HW et al (2011) Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol 200:1-5
33. Raggam RB, Bozic M, Salzer HJ, Hammerschmidt S, Homberg C et al (2010) Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR. Med Microbiol Immunol 199:311-316
34. Sun Z, Ceng X, Mao Z, Wang J, Liu Q et al (2009) Diagnostic value of HCMV pp65 antigen detection by FCA for symptomatic and asymptomatic infection: compared to quantification of HCMV DNA and detection of IgM antibody in infants. Med Microbiol Immunol 198:107-112
35. Kampmann SE, Schindele B, Apelt L, Buhrer C, Garten L et al (2011) Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection. Med Microbiol Immunol 200:109-113
36. Ogbomo H, Geiler J, Leutz A, von Kietzell K, Michaelis M et al (2009) Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method. Med Microbiol Immunol 198:257-262
37. Bleymehl K, Cinatl J, Schmidt-Chanasit J (2011) Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet. Med Microbiol Immunol 200:193-202
38. Wu F, Xing J, Wang S, Li M, Zheng C (2011) Screening and identification of host factors interacting with UL14 of herpes simplex virus 1. Med Microbiol Immunol 200:203-208
39. Sauerbrei A, Stefanski J, Philipps A, Krumbholz A, Zell R et al (2011) Monitoring prevalence of varicella-zoster virus clades in Germany. Med Microbiol Immunol 200:99-107
40. Schmidt-Chanasit J, Bleymehl K, Schad SG, Gross G, Ulrich RG et al (2008) Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. J Clin Microbiol 46:325-327
41. Daumer MP, Schneider B, Giesen DM, Aziz S, Kaiser R et al (2011) Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity. Med Microbiol Immunol 200:85-97
42. Wesolowski J, Alzogaray V, Reyelt J, Unger M, Juarez K et al (2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol 198:157-174
43. Hunig T, Luhder F, Elflein K, Gogishvili T, Frohlich M et al (2010) CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation. Med Microbiol Immunol 199:239-246
44. Avota E, Gassert E, Schneider-Schaulies S (2010) Measles virusinduced immunosuppression: from effectors to mechanisms. Med Microbiol Immunol 199:227-237
45. Reuter D, Schneider-Schaulies J (2010) Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol 199:261-271
46. Dobrindt U, Chowdary MG, Krumbholz G, Hacker J (2010) Genome dynamics and its impact on evolution of Escherichia coli. Med Microbiol Immunol 199:145-154
47. Gross R, Keidel K, Schmitt K (2010) Resemblance and divergence: the "new" members of the genus Bordetella. Med Microbiol Immunol 199:155-163
48. Schielke S, Frosch M, Kurzai O (2010) Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae. Med Microbiol Immunol 199:185-196
49. Lappann M, Vogel U (2010) Biofilm formation by the human pathogen Neisseria meningitidis. Med Microbiol Immunol 199:173-183
50. Morschhauser J (2010) Regulation of white-opaque switching in Candida albicans. Med Microbiol Immunol 199:165-172
51. Brehm K (2010) The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and hostparasite interaction. Med Microbiol Immunol 199:247-259
52. Biru T, Lennemann T, Sturmer M, Stephan C, Nisius G et al (2010) Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis. Med Microbiol Immunol 199:323-332
53. Higuchi K, Kawabe Y, Mitarai S, Yoshiyama T, Harada N et al (2009) Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol 198:33-37
54. Kumar M, Sundaramurthi JC, Mehra NK, Kaur G, Raja A (2010) Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India. Med Microbiol Immunol 199:11-25
55. Wang C, Chen Z, Fu R, Zhang Y, Chen L et al (2011) A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice. Med Microbiol Immunol 200:165-175
56. Wang J, Qie Y, Zhu B, Zhang H, Xu Y et al (2009) Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice. Med Microbiol Immunol 198:5-11
57. Huygen K, Adjei O, Affolabi D, Bretzel G, Demangel C et al (2009) Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol 198:69-77
58. Zimecki M, Artym J, Kocieba M, Weber-Dabrowska B, Borysowski J et al (2010) Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus. Med Microbiol Immunol 199:71-79
59. Makidon PE, Knowlton J, Groom JV 2nd, Blanco LP, LiPuma JJ et al (2010) Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. Med Microbiol Immunol 199:81-92
60. Uppada JB, Khan AA, Bhat AA, Deshmukh R, Rao DN (2009) Humoral immune responses and protective efficacy of sequential B-and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles. Med Microbiol Immunol 198:247-256
61. Errea A, Moreno G, Sisti F, Fernandez J, Rumbo M et al (2010) Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization. Med Microbiol Immunol 199:103-108
62. Roop RM II, Gaines JM, Anderson ES, Caswell CC, Martin DW (2009) Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host. Med Microbiol Immunol 198:221-238
63. Kloft N, Neukirch C, Bobkiewicz W, Veerachato G, Busch T et al (2010) Pro-autophagic signal induction by bacterial poreforming toxins. Med Microbiol Immunol 199:299-309
64. Logters T, Margraf S, Altrichter J, Cinatl J, Mitzner S et al (2009) The clinical value of neutrophil extracellular traps. Med Microbiol Immunol 198:211-219
65. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ et al (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187:23-42
66. Mannonen L, Markkula E, Puolakkainen M (2011) Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts. Med Microbiol Immunol 200:143-154
67. Shima K, Kuhlenbaumer G, Rupp J (2010) Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember? Med Microbiol Immunol 199:283-289
68. Miklossy J (2011) Alzheimer's disease-a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 8:90
69. Mertens M, Hofmann J, Petraityte-Burneikiene R, Ziller M, Sasnauskas K et al (2011) Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava-Belgrade hantaviruses. Med Microbiol Immunol 200:263-268
70. Mertens M, Wolfel R, Ullrich K, Yoshimatsu K, Blumhardt J et al (2009) Seroepidemiological study in a Puumala virus outbreak area in South-East Germany. Med Microbiol Immunol 198:83-91
71. Tappe D, Schmidt-Chanasit J, Ries A, Ziegler U, Muller A et al (2009) Ross River virus infection in a traveller returning from northern Australia. Med Microbiol Immunol 198:271-273
72. Allwinn R (2011) Significant increase in travel-associated dengue fever in Germany. Med Microbiol Immunol 200:155-159
73. Panning M, Wichmann D, Grywna K, Annan A, Wijesinghe S et al (2009) No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka. Med Microbiol Immunol 198:103-106
74. Maurer M, Dondji B, von Stebut E (2009) What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis. Med Microbiol Immunol 198:137-146